contact:
- name: "Universit\xE4tsmedizin Greifswald"
  telecom:
  - system: url
    value: https://www.medizin.uni-greifswald.de/
definition:
  page:
    generation: html
    name: toc.html
    page:
    - generation: markdown
      name: index.html
      sourceUrl: index.html
      title: CELIDA Recommendations
    - generation: html
      name: downloads.html
      sourceUrl: downloads.html
      title: Downloads
    - generation: markdown
      name: changelog.html
      sourceUrl: changelog.html
      title: Change Log
    sourceUrl: toc.html
    title: Table of Contents
  parameter:
  - code:
      code: copyrightyear
      system: http://hl7.org/fhir/tools/CodeSystem/ig-parameters
    value: 2021+
  - code:
      code: releaselabel
      system: http://hl7.org/fhir/tools/CodeSystem/ig-parameters
    value: ci-build
  - code:
      code: active-tables
      system: http://hl7.org/fhir/tools/CodeSystem/ig-parameters
    value: 'true'
  - code:
      code: apply-contact
      system: http://hl7.org/fhir/tools/CodeSystem/ig-parameters
    value: 'false'
  - code:
      code: apply-jurisdiction
      system: http://hl7.org/fhir/tools/CodeSystem/ig-parameters
    value: 'false'
  - code:
      code: apply-publisher
      system: http://hl7.org/fhir/tools/CodeSystem/ig-parameters
    value: 'false'
  - code:
      code: apply-version
      system: http://hl7.org/fhir/tools/CodeSystem/ig-parameters
    value: 'false'
  - code:
      code: show-inherited-invariants
      system: http://hl7.org/fhir/tools/CodeSystem/ig-parameters
    value: 'false'
  - code:
      code: usage-stats-opt-out
      system: http://hl7.org/fhir/tools/CodeSystem/ig-parameters
    value: 'true'
  - code:
      code: excludexml
      system: http://hl7.org/fhir/tools/CodeSystem/ig-parameters
    value: 'false'
  - code:
      code: excludejsn
      system: http://hl7.org/fhir/tools/CodeSystem/ig-parameters
    value: 'false'
  - code:
      code: excludettl
      system: http://hl7.org/fhir/tools/CodeSystem/ig-parameters
    value: 'true'
  - code:
      code: excludemap
      system: http://hl7.org/fhir/tools/CodeSystem/ig-parameters
    value: 'true'
  - code:
      code: excludeexample
      system: http://hl7.org/fhir/tools/CodeSystem/ig-parameters
    value: 'true'
  - code:
      code: extension-domain
      system: http://hl7.org/fhir/tools/CodeSystem/ig-parameters
    value: https://www.netzwerk-universitaetsmedizin.de
  - code:
      code: extension-domain
      system: http://hl7.org/fhir/tools/CodeSystem/ig-parameters
    value: https://simplifier.net
  resource:
  - description: In ARDS and a PaO2/FiO2 < 150 mmHg, abdominal positioning should
      be consistently performed, with an abdominal positioning interval of at least
      16 hours.
    isExample: false
    name: Abdominal Positioning
    reference:
      reference: ActivityDefinition/PronePositioning
  - description: In ARDS and a PaO2/FiO2 < 150 mmHg, abdominal positioning should
      be consistently performed, with an abdominal positioning interval of at least
      16 hours.
    isExample: false
    name: Abdominal positioning plan in case of ARDS and a PaO2/FiO2 < 150 mmHg
    reference:
      reference: PlanDefinition/AbdominalPositioningARDSPlan
  - description: In intensive care patients without a specific indication (e.g. pulmonary
      embolism), therapeutic anticoagulation should not be given.
    isExample: false
    name: Anticoagulation Plan for hospitalized intensive-care COVID-19 patients with
      no specific indication
    reference:
      reference: PlanDefinition/NoTherapeuticAnticoagulationICUCOVID19NoIndicationPlan
  - description: Antithrombotic prophylaxis with Certoparin in hospitalised COVID-19
      patients (in absence of contraindications for LWMH)
    isExample: false
    name: Antithrombotic prophylaxis with Certoparin
    reference:
      reference: ActivityDefinition/ProphylacticAnticoagulationWCertoparin
  - description: Antithrombotic prophylaxis with Dalteparin in hospitalised COVID-19
      patients (in absence of contraindications for LWMH)
    isExample: false
    name: Antithrombotic prophylaxis with Dalteparin
    reference:
      reference: ActivityDefinition/ProphylacticAnticoagulationWDalteparin
  - description: Antithrombotic prophylaxis with Enoxaparin in hospitalised COVID-19
      patients (in absence of contraindications for LWMH)
    isExample: false
    name: Antithrombotic prophylaxis with Enoxaparin
    reference:
      reference: ActivityDefinition/ProphylacticAnticoagulationWEnoxaparin
  - description: Antithrombotic prophylaxis with Fondaparinux in hospitalised COVID-19
      patients
    isExample: false
    name: Antithrombotic prophylaxis with Fondaparinux
    reference:
      reference: PlanDefinition/AntithrombFondapProphInHospitalisedCOVID19PatientsRecommPlan
  - description: Antithrombotic prophylaxis with Fondaparinux in hospitalised COVID-19
      patients (when contraindications for LWMH exist)
    isExample: false
    name: Antithrombotic prophylaxis with Fondaparinux
    reference:
      reference: ActivityDefinition/AntithromboticProphylaxisFondaparinuxSubcutaneous
  - description: Hospitalized patients with COVID-19 should receive standard drug
      thromboembolism prophylaxis with low molecular weight heparin in the absence
      of contraindications. Alternatively, fondaparinux may be used.
    isExample: false
    name: Antithrombotic prophylaxis with LWMH
    reference:
      reference: PlanDefinition/AntithrombLWMHProphInHospitalisedCOVID19PatientsRecommPlan
  - description: Antithrombotic prophylaxis with Nadroparin in hospitalised COVID-19
      patients (in absence of contraindications for LWMH)
    isExample: false
    name: Antithrombotic prophylaxis with Nadroparin
    reference:
      reference: ActivityDefinition/ProphylacticAnticoagulationWNadroparin
  - description: Antithrombotic prophylaxis with Tinzaparin in hospitalised COVID-19
      patients
    isExample: false
    name: Antithrombotic prophylaxis with Tinzaparin
    reference:
      reference: ActivityDefinition/ProphylacticAnticoagulationWTinzaparin
  - description: Concepts required in recommendations that are not defined elsewhere
    isExample: false
    name: CODEX-CELIDA
    reference:
      reference: CodeSystem/codex-celida
  - description: Hospitalised COVID-19 patients, treated on ICU, without thrombembolic
      complication
    isExample: false
    name: Hospitalised COVID-19 patients, treated on ICU, without thrombembolic complication
    reference:
      reference: EvidenceVariable/PopHospitalisedICUCOVID19Patients
  - description: Klassifizierung eines Kontaktes mit einer Gesundheitseinrichtung
    isExample: false
    name: KontaktArtDe
    reference:
      reference: CodeSystem/KontaktArtDe
  - description: No Therapeutic Anticoagulation Treatment with Argatroban for non-intensive
      care hospitalised COVID-19 patients patients with no specific indications (i.e.,
      pulmonary embolism)
    isExample: false
    name: No Therapeutic Anticoagulation Treatment with Argatroban
    reference:
      reference: ActivityDefinition/NoTherapeuticAnticoagulationWArgatra
  - description: No Therapeutic Anticoagulation Treatment with Certoparin for non-intensive
      care hospitalised COVID-19 patients patients with no specific indications (i.e.,
      pulmonary embolism)
    isExample: false
    name: No Therapeutic Anticoagulation Treatment with Certoparin
    reference:
      reference: ActivityDefinition/NoTherapeuticAnticoagulationWCertoparin
  - description: No Therapeutic Anticoagulation Treatment with Dalteparin for non-intensive
      care hospitalised COVID-19 patients patients with no specific indications (i.e.,
      pulmonary embolism)
    isExample: false
    name: No Therapeutic Anticoagulation Treatment with Dalteparin
    reference:
      reference: ActivityDefinition/NoTherapeuticAnticoagulationWDalteparin1xd
  - description: No Therapeutic Anticoagulation Treatment with Dalteparin for non-intensive
      care hospitalised COVID-19 patients patients with no specific indications (i.e.,
      pulmonary embolism)
    isExample: false
    name: No Therapeutic Anticoagulation Treatment with Dalteparin
    reference:
      reference: ActivityDefinition/NoTherapeuticAnticoagulationWDalteparin2xd
  - description: No Therapeutic Anticoagulation Treatment with Dalteparin for non-intensive
      care hospitalised COVID-19 patients patients with no specific indications (i.e.,
      pulmonary embolism)
    isExample: false
    name: No Therapeutic Anticoagulation Treatment with Dalteparin
    reference:
      reference: ActivityDefinition/NoTherapeuticAnticoagulationWDalteparinTable
  - description: No Therapeutic Anticoagulation Treatment with Enoxaparin for non-intensive
      care hospitalised COVID-19 patients patients with no specific indications (i.e.,
      pulmonary embolism)
    isExample: false
    name: No Therapeutic Anticoagulation Treatment with Enoxaparin
    reference:
      reference: ActivityDefinition/NoTherapeuticAnticoagulationWEnoxaparin1xd
  - description: No Therapeutic Anticoagulation Treatment with Enoxaparin for non-intensive
      care hospitalised COVID-19 patients patients with no specific indications (i.e.,
      pulmonary embolism)
    isExample: false
    name: No Therapeutic Anticoagulation Treatment with Enoxaparin
    reference:
      reference: ActivityDefinition/NoTherapeuticAnticoagulationWEnoxaparin2xd
  - description: No Therapeutic Anticoagulation Treatment with Fondaparinux for non-intensive
      care hospitalised COVID-19 patients patients with no specific indications (i.e.,
      pulmonary embolism)
    isExample: false
    name: NO Therapeutic Anticoagulation Treatment with Fondaparinux
    reference:
      reference: ActivityDefinition/NoTherapeuticAnticoagulationFondaparinux
  - description: No Therapeutic Anticoagulation Treatment with Nadroparin for non-intensive
      care hospitalised COVID-19 patients patients with no specific indications (i.e.,
      pulmonary embolism)
    isExample: false
    name: No Therapeutic Anticoagulation Treatment with Nadroparin
    reference:
      reference: ActivityDefinition/NoTherapeuticAnticoagulationWNadroparin
  - description: No Therapeutic Anticoagulation Treatment with Tinzaparin for non-intensive
      care hospitalised COVID-19 patients patients with no specific indications (i.e.,
      pulmonary embolism)
    isExample: false
    name: No Therapeutic Anticoagulation Treatment with Tinzaparin
    reference:
      reference: ActivityDefinition/NoTherapeuticAnticoagulationWTinzaparin
  - description: No Therapeutic Anticoagulation Treatment with UFH for non-intensive
      care hospitalised COVID-19 patients patients with no specific indications (i.e.,
      pulmonary embolism)
    isExample: false
    name: No Therapeutic Anticoagulation Treatment with UFH
    reference:
      reference: ActivityDefinition/NoTherapeuticAnticoagulationWUFH
  - description: PEEP Intervention Plan for Ventilated COVID-19 Patients, inspiratory
      oxygen fraction currently 0.0 - 0.39
    isExample: false
    name: 'PEEP Intervention Plan for Population: Ventilated COVID-19 Patients, inspiratory
      oxygen fraction currently 0.0'
    reference:
      reference: PlanDefinition/VentilatedCOVID19patientsInterventionPlan-fio2-point0
  - description: PEEP Intervention Plan for Ventilated COVID-19 Patients, inspiratory
      oxygen fraction currently 043 - 0.49
    isExample: false
    name: 'PEEP Intervention Plan for Population: Ventilated COVID-19 Patients, inspiratory
      oxygen fraction currently 0.4'
    reference:
      reference: PlanDefinition/VentilatedCOVID19patientsInterventionPlan-fio2-point4
  - description: PEEP Intervention Plan for Ventilated COVID-19 Patients, inspiratory
      oxygen fraction currently 0.5 - 0.59
    isExample: false
    name: 'PEEP Intervention Plan for Population: Ventilated COVID-19 Patients, inspiratory
      oxygen fraction currently 0.5'
    reference:
      reference: PlanDefinition/VentilatedCOVID19patientsInterventionPlan-fio2-point5
  - description: PEEP Intervention Plan for Ventilated COVID-19 Patients, inspiratory
      oxygen fraction currently 0.6 - 0.69
    isExample: false
    name: 'PEEP Intervention Plan for Population: Ventilated COVID-19 Patients, inspiratory
      oxygen fraction currently 0.6'
    reference:
      reference: PlanDefinition/VentilatedCOVID19patientsInterventionPlan-fio2-point6
  - description: PEEP Intervention Plan for Ventilated COVID-19 Patients, inspiratory
      oxygen fraction currently 0.7 - 0.79
    isExample: false
    name: 'PEEP Intervention Plan for Population: Ventilated COVID-19 Patients, inspiratory
      oxygen fraction currently 0.7'
    reference:
      reference: PlanDefinition/VentilatedCOVID19patientsInterventionPlan-fio2-point7
  - description: PEEP Intervention Plan for Ventilated COVID-19 Patients, inspiratory
      oxygen fraction currently 0.8 - 0.89
    isExample: false
    name: 'PEEP Intervention Plan for Population: Ventilated COVID-19 Patients, inspiratory
      oxygen fraction currently 0.8'
    reference:
      reference: PlanDefinition/VentilatedCOVID19patientsInterventionPlan-fio2-point8
  - description: PEEP Intervention Plan for Ventilated COVID-19 Patients, inspiratory
      oxygen fraction currently 0.9 - 0.99
    isExample: false
    name: 'PEEP Intervention Plan for Population: Ventilated COVID-19 Patients, inspiratory
      oxygen fraction currently 0.9'
    reference:
      reference: PlanDefinition/VentilatedCOVID19patientsInterventionPlan-fio2-point9
  - description: PEEP Intervention Plan for Ventilated COVID-19 Patients, inspiratory
      oxygen fraction currently 1.0 - 1.09
    isExample: false
    name: 'PEEP Intervention Plan for Population: Ventilated COVID-19 Patients, inspiratory
      oxygen fraction currently 1.0'
    reference:
      reference: PlanDefinition/VentilatedCOVID19patientsInterventionPlan-fio2-1
  - description: 'Population for recommendation 15: Hospitalised COVID-19 patients
      with existing contraindications to LWMH'
    isExample: false
    name: 'Population: Hospitalised COVID-19 patients with existing contraindications
      to LWMH'
    reference:
      reference: EvidenceVariable/PopHospitalisedCOVID19PatientsWithContraIndications
  - description: 'Population for recommendation 15: Hospitalised COVID-19 patients
      without contraindications to LWMH'
    isExample: false
    name: 'Population: Hospitalised COVID-19 patients without contraindications to
      LWMH'
    reference:
      reference: EvidenceVariable/PopHospitalisedCOVID19PatientsWOContraIndications
  - description: 'Population for recommendation 17 from guideline from https://www.awmf.org/leitlinien/detail/ll/113-001LG.html
      with characteristics: without the need for intensive care therapy, considered
      high-risk for developing venous thrombosis'
    isExample: false
    name: 'Population: Hospitalised COVID-19 patients without the need for intensive
      care therapy considered high-risk for developing venous thrombosis'
    reference:
      reference: EvidenceVariable/PopHospitalisedNonICUCOVID19PatientsWITHHighRisk
  - description: Ventilated COVID-19 patients with ARDS
    isExample: false
    name: 'Population: Ventilated COVID-19 Patients with ARDS'
    reference:
      reference: EvidenceVariable/PopulationVentilatedCOVID19patientsWithARDS
  - description: Ventilated COVID-19 patients with severe ARDS, defined by oxygenation
      failure (Horovitz Quotient lower than 150)
    isExample: false
    name: 'Population: Ventilated COVID-19 Patients with severe ARDS'
    reference:
      reference: EvidenceVariable/PopVentilatedCOVID19patientsWithARDSWithOxygenationFailure
  - description: Ventilated COVID-19 patients, inspiratory oxygen fraction currently
      0.0 - 0.39
    isExample: false
    name: 'Population: Ventilated COVID-19 Patients, inspiratory oxygen fraction currently
      0.0'
    reference:
      reference: EvidenceVariable/PopulationVentilatedCOVID19patients-fio2-point0
  - description: Ventilated COVID-19 patients, inspiratory oxygen fraction currently
      0.4 - 0.49
    isExample: false
    name: 'Population: Ventilated COVID-19 Patients, inspiratory oxygen fraction currently
      0.4'
    reference:
      reference: EvidenceVariable/PopulationVentilatedCOVID19patients-fio2-point4
  - description: Ventilated COVID-19 patients, inspiratory oxygen fraction currently
      0.5 - 0.59
    isExample: false
    name: 'Population: Ventilated COVID-19 Patients, inspiratory oxygen fraction currently
      0.5'
    reference:
      reference: EvidenceVariable/PopulationVentilatedCOVID19patients-fio2-point5
  - description: Ventilated COVID-19 patients, inspiratory oxygen fraction currently
      0.6 - 0.69
    isExample: false
    name: 'Population: Ventilated COVID-19 Patients, inspiratory oxygen fraction currently
      0.6'
    reference:
      reference: EvidenceVariable/PopulationVentilatedCOVID19patients-fio2-point6
  - description: Ventilated COVID-19 patients, inspiratory oxygen fraction currently
      0.7 - 0.79
    isExample: false
    name: 'Population: Ventilated COVID-19 Patients, inspiratory oxygen fraction currently
      0.7'
    reference:
      reference: EvidenceVariable/PopulationVentilatedCOVID19patients-fio2-point7
  - description: Ventilated COVID-19 patients, inspiratory oxygen fraction currently
      0.8 - 0.89
    isExample: false
    name: 'Population: Ventilated COVID-19 Patients, inspiratory oxygen fraction currently
      0.8'
    reference:
      reference: EvidenceVariable/PopulationVentilatedCOVID19patients-fio2-point8
  - description: Ventilated COVID-19 patients, inspiratory oxygen fraction currently
      0.9 - 0.99
    isExample: false
    name: 'Population: Ventilated COVID-19 Patients, inspiratory oxygen fraction currently
      0.9'
    reference:
      reference: EvidenceVariable/PopulationVentilatedCOVID19patients-fio2-point9
  - description: Ventilated COVID-19 patients, inspiratory oxygen fraction currently
      1.0
    isExample: false
    name: 'Population: Ventilated COVID-19 Patients, inspiratory oxygen fraction currently
      1.0'
    reference:
      reference: EvidenceVariable/PopulationVentilatedCOVID19patients-fio2-1
  - description: Patients with ARDS
    isExample: false
    name: 'Population: Ventilated patients with ARDS'
    reference:
      reference: EvidenceVariable/PopulationVentilatedARDSPatients
  - description: Prophylactic Treatment with UFH subcutaneous for non-intensive care
      hospitalised COVID-19 patients
    isExample: false
    name: Prophylactic Anticoagulation Treatment with UFH subcutaneous
    reference:
      reference: ActivityDefinition/ProphylacticAnticoagulationWHeparinSC
  - description: Recommendation Collection for ICU COVID-19 Patients with No Specific
      Indication
    isExample: false
    name: 'Recommendation Collection: ICU COVID-19 Patients with No Specific Indication'
    reference:
      reference: PlanDefinition/RecCollectionNoTherapeuticAnticoagNoIndicationICUCOVID19
  - description: Recommendation Collection for Patients with ARDS and a PaO2/FiO2
      < 150 mmHg
    isExample: false
    name: 'Recommendation Collection: Patients with ARDS and a PaO2/FiO2 < 150 mmHg'
    reference:
      reference: PlanDefinition/RecommendationCollectionAbdominalPositioningARDS
  - description: Recommendation Collection for Hospitalized COVID-19 Patients
    isExample: false
    name: 'Recommendation Collection: Prophylactic Anticoagulation in Hospitalized
      COVID-19 Patients'
    reference:
      reference: PlanDefinition/RecCollectionProphAnticoagulationHospitalizedCOVID19Patients
  - description: Recommendation Collection for non-ICU, High-Risk COVID-19 Patients
    isExample: false
    name: 'Recommendation Collection: Therapeutic Anticoagulation in Non-ICU, High-Risk
      COVID-19 Patients'
    reference:
      reference: PlanDefinition/RecCollectionTherapeuticAnticoagNonICUHighRiskCOVID19Patients
  - description: Recommendation Collection for Ventilated COVID-19 Patients
    isExample: false
    name: 'Recommendation Collection: Ventilated COVID-19 Patients'
    reference:
      reference: PlanDefinition/RecommendationCollectionVentilatedCOVID19patients
  - description: Recommendation Collection for Ventilated Patients with ARDS
    isExample: false
    name: 'Recommendation Collection: Ventilated Patients with ARDS'
    reference:
      reference: PlanDefinition/RecommendationCollectionVentilatedPatientsWithARDS
  - description: Recommendation Collection for Ventilated COVID-19 patients with ARDS
    isExample: false
    name: 'Recommendation Collection: Ventilation Plan for Ventilated COVID-19 patients
      with ARDS'
    reference:
      reference: PlanDefinition/RecommendationCollectionVentilationCOVID19patientsWithARDS
  - description: "In hospitalized, non-intensive care patients with COVID-19 and increased\
      \ risk (e.g., D-dimers \u2265 2 mg/l), therapeutic anticoagulation can be considered\
      \ if the risk of bleeding is low. Anticoagulation, preferentially with NMH or\
      \ UFH, can be considered."
    isExample: false
    name: Therapeutic Anticoagulation Plan (hospitalised, non-intensive care, COVID-19
      patients with no renal function impairment (eGFR >= 30ml/min))
    reference:
      reference: PlanDefinition/TherapeuticAnticoagulationNonICUHighRiskCOVID19PatientsPlan
  - description: Therapeutic Anticoagulation Treatment (UFH) for non-intensive care
      hospitalised COVID-19 patients patients with high risk (D-Dimer >= 2mg/l)
    isExample: false
    name: Therapeutic Anticoagulation Treatment UFH
    reference:
      reference: ActivityDefinition/TherapeuticAnticoagulationUFH
  - description: Therapeutic Anticoagulation Treatment with Argatroban for non-intensive
      care hospitalised COVID-19 patients patients with no specific indications (i.e.,
      pulmonary embolism)
    isExample: false
    name: Therapeutic Anticoagulation Treatment with Argatroban
    reference:
      reference: ActivityDefinition/TherapeuticAnticoagulationWArgatra
  - description: Therapeutic Anticoagulation Treatment (NMH) for non-intensive care
      hospitalised COVID-19 patients patients with high risk (D-Dimer >= 2mg/l) with
      Certoparin
    isExample: false
    name: Therapeutic Anticoagulation Treatment with Certoparin
    reference:
      reference: ActivityDefinition/TherapeuticAnticoagulationNMHCertoparin
  - description: Therapeutic Anticoagulation Treatment (NMH) for non-intensive care
      hospitalised COVID-19 patients patients with high risk (D-Dimer >= 2mg/l) with
      Dalteparin
    isExample: false
    name: Therapeutic Anticoagulation Treatment with Dalteparin
    reference:
      reference: ActivityDefinition/TherapeuticAnticoagulationNMHDalteparin1xd
  - description: Therapeutic Anticoagulation Treatment (NMH) for non-intensive care
      hospitalised COVID-19 patients patients with high risk (D-Dimer >= 2mg/l) with
      Dalteparin
    isExample: false
    name: Therapeutic Anticoagulation Treatment with Dalteparin
    reference:
      reference: ActivityDefinition/TherapeuticAnticoagulationNMHDalteparin2xd
  - description: Therapeutic Anticoagulation Treatment (NMH) for non-intensive care
      hospitalised COVID-19 patients patients with high risk (D-Dimer >= 2mg/l) with
      Dalteparin
    isExample: false
    name: Therapeutic Anticoagulation Treatment with Dalteparin
    reference:
      reference: ActivityDefinition/TherapeuticAnticoagulationNMHDalteparinTable
  - description: Therapeutic Anticoagulation Treatment (NMH) for non-intensive care
      hospitalised COVID-19 patients patients with high risk (D-Dimer >= 2mg/l) with
      Enoxaparin
    isExample: false
    name: Therapeutic Anticoagulation Treatment with Enoxaparin
    reference:
      reference: ActivityDefinition/TherapeuticAnticoagulationNMHEnoxaparin1xd
  - description: Therapeutic Anticoagulation Treatment (NMH) for non-intensive care
      hospitalised COVID-19 patients patients with high risk (D-Dimer >= 2mg/l) with
      Enoxaparin
    isExample: false
    name: Therapeutic Anticoagulation Treatment with Enoxaparin
    reference:
      reference: ActivityDefinition/TherapeuticAnticoagulationNMHEnoxaparin2xd
  - description: Therapeutic Anticoagulation Treatment with Fondaparinux for non-intensive
      care hospitalised COVID-19 patients patients with no specific indications (i.e.,
      pulmonary embolism)
    isExample: false
    name: Therapeutic Anticoagulation Treatment with Fondaparinux
    reference:
      reference: ActivityDefinition/TherapeuticAnticoagulationFondaparinux
  - description: Therapeutic Anticoagulation Treatment (NMH) for non-intensive care
      hospitalised COVID-19 patientswith high risk (D-Dimer >= 2mg/l) with Nadroparin
    isExample: false
    name: Therapeutic Anticoagulation Treatment with Nadroparin
    reference:
      reference: ActivityDefinition/TherapeuticAnticoagulationNMHNadroparin
  - description: Therapeutic Anticoagulation Treatment (NMH) for non-intensive care
      hospitalised COVID-19 patients patients with high risk (D-Dimer >= 2mg/l) with
      Tinzaparin
    isExample: false
    name: Therapeutic Anticoagulation Treatment with Tinzaparin
    reference:
      reference: ActivityDefinition/TherapeuticAnticoagulationNMHTinzaparin
  - description: "In ventilated patients with COVID-19 and ARDS, tidal volume should\
      \ be \u2264 6 ml/kg standard body weight, end-inspiratory airway pressure \u2264\
      \ 30 cm H2O."
    isExample: false
    name: Ventilation Plan for COVID-19 patients with ARDS
    reference:
      reference: PlanDefinition/VentilatedCOVID19PatientsWithARDSVentilationPlan
  - description: "We recommend ventilating patients with ARDS with a VT \u2264 6 ml/kg\
      \ standard body weight (bw). (Table 1, Appendix)"
    isExample: false
    name: Ventilation Plan for patients with ARDS
    reference:
      reference: PlanDefinition/VentilatedARDSPatientsInterventionPlan
dependsOn:
- id: de_netzwerk_universitaetsmedizin_ebm_cpg
  packageId: de.netzwerk-universitaetsmedizin.ebm-cpg
  uri: https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ImplementationGuide/de.netzwerk-universitaetsmedizin.ebm-cpg
  version: 0.8.0-snapshot
fhirVersion:
- 5.0.0
id: recommendations.celida.codex.netzwerk-universitaetsmedizin.de
name: CELIDARecommendations
packageId: recommendations.celida.codex.netzwerk-universitaetsmedizin.de
publisher: "Universit\xE4tsmedizin Greifswald"
resourceType: ImplementationGuide
status: draft
title: CODEX+ CELIDA Recommendations
url: https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/ImplementationGuide/recommendations.celida.codex.netzwerk-universitaetsmedizin.de
version: 1.5.1-snapshot
